Prevalence of Lower Limb Lymphedema in Gynecological Cancer: A State-of-the-Art

Patients having vulvar cancer should be particularly concerned about lower limb lymphedema (LLL). The frequency of vulvar cancer-related lymphedema, as well as the factors that contribute, has increased dramatically. This article is a state-of-the-art review that intends to assess the prevalence of LLL and its factors connected with vulvar disease. Data were gathered from PubMed, Science Direct, Web of Science, Scopus, and Cochrane from 2000 to 2017 in the English language. Random impact models were utilized to compute a pooled by and large gauge of LLL rate, and subgroup investigations were performed to evaluate the impacts of various review plans, nations of study beginning, analytic strategies, and degree of lymph flow. Fifteen studies met the incorporation standards for evaluating lymphedema rate with forthcoming examinations. The occurrence of LLL was expanded by roughly 7-overlay in females who underwent inguinofemoral lymph analyzation contrasted with individuals who underwent sentinel lymph biopsy. The revealed risk factors include injury, disease, inguinofemoral lymphadenectomy, age, and weight list (body mass index), and radiation treatment. Approximately 3 of every 10 females who endure vulvar disease, foster LLL. More research focusing on comprehension of its factors and fostering anticipation and the board systems can reduce its upsetting confusion which is the need of the hour.